Picture of Gritstone bio logo

GRTSQ — Gritstone bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Gritstone bio Inc expected to post a loss of 32 cents a share - Earnings Preview

* Gritstone bio Inc  GRTS.OQ   GRTS.O  is expected to show a
fall
in quarterly revenue when it reports  results on May 9 for the
period ending March 31 2024
    * The Emeryville California-based  company is expected to
report a
54.8% decrease in revenue to $1.104 million from $2.44 million a
year ago, according to the mean estimate from 6 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Gritstone bio Inc is for
a
loss of 32 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 4.4%
in the last three months. ​
    * Wall Street's median 12-month price target for Gritstone
bio Inc
is $4.00​, above​ its last closing price of $1.01. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.31       -0.33      -0.26     Beat    20.7
 Sep. 30 2023  -0.31       -0.33      -0.33     Met     0.9
 Jun. 30 2023  -0.33       -0.35      -0.31     Beat    10.5​
 Mar. 31 2023  -0.33       -0.33      -0.30     Beat    10.3
 ​​Dec.        -0.31       -0.34      -0.30     Beat    12.8
 31 2022                                                
 Jan. 1 0001   -0.37       -0.40      -0.35     Beat    12.1​
 Jun. 30 2022  -0.39       -0.40      -0.34     Beat    14.1
 Mar. 31 2022  -0.35       -0.37      -0.34     Beat    7.5
 This summary was machine generated May 8 at 02:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Gritstone bio

See all news